Doug Hampton

Freya Pharma Solutions Announces Response from the FDA on its US Clinical Development Program of LybridoTM for the treatment of Female Sexual Interest/Arousal Disorder

by

AMSTERDAM, June 19, 2023 /PRNewswire/ — Freya Pharma Solutions, a pharmaceutical company dedicated to developing effective pharmaceutical therapies for women diagnosed with Female Sexual Disorders (FSD), announced today that the United States (US) Food and Drug Administration (FDA) has responded with interest and provided valuable input regarding Freya Pharma’s request for advice on the US Clinical … Read more

Medivir’s patent application for fostrox approved in China

by

STOCKHOLM, June 19, 2023 /PRNewswire/ — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces today that the company’s patent application, covering both substance claims for fostroxacitabine bralpamide (fostrox) and its use for liver cancer treatment, has recently been approved by … Read more

DRAGONFLY-DMR 12-Month Trial Results Revealed at EuroPCR 2023

by

First-Time Clinical Trial Outcomes Show Promising Follow-Up Results HANGZHOU, China, June 19, 2023 /PRNewswire/ — On May 17th, the 12-month results of the DRAGONFLY-DMR pivotal trial were presented at EuroPCR 2023. This trial was led by Professor Jian’an Wang from Zhe’er Hospital, Hangzhou, China, and presented on his behalf by the Eligibility Committee Chair, Professor … Read more

The Summit Forum on the Application and Construction of AGP in China Takes Place in Shenzhen

by

SHENZHEN, China, June 19, 2023 /PRNewswire/ — On June 9, the Summit Forum on the Application and Construction of AGP in China, led by the National Innovation Center for Advanced Medical Devices, sponsored by China AGP and Digital Therapeutics R&D Center (hereafter referred to as the “R&D Center”), co-sponsored by Shenzhen SiBionics Technology Co., Ltd. (hereafter … Read more

Beactica Therapeutics appoints Jarl Ulf Jungnelius M.D. to its Board of Directors as it advances towards clinical-stage activities

by

STOCKHOLM, June 19, 2023 /PRNewswire/ — Beactica Therapeutics AB, the Swedish precision oncology company, today announced the appointment of Jarl Ulf Jungnelius M.D. to its Board of Directors. The appointment marks another step in Beactica’s strategic plan to become a clinical-stage company. Jarl Ulf Jungnelius M.D. is a licensed medical practitioner and a board-certified oncologist … Read more

Beactica Therapeutics appoints Jarl Ulf Jungnelius M.D. to its Board of Directors as it advances towards clinical-stage activities

by

STOCKHOLM, June 19, 2023 /PRNewswire/ — Beactica Therapeutics AB, the Swedish precision oncology company, today announced the appointment of Jarl Ulf Jungnelius M.D. to its Board of Directors. The appointment marks another step in Beactica’s strategic plan to become a clinical-stage company. Jarl Ulf Jungnelius M.D. is a licensed medical practitioner and a board-certified oncologist … Read more

Genomics Market Size to Grow by USD 18,244.34 million from 2022 to 2027, North America is estimated to contribute 37% to the global market growth

by

NEW YORK, June 19, 2023 /PRNewswire/ — The global genomics market size is estimated to increase by USD 18,244.34 million from 2022 to 2027. The market’s growth momentum will progress at a CAGR of 10.53% during the forecast period. Discover some insights on market size historic period (2017 to 2021) and Forecast (2023 to 2027) before buying the … Read more

Nippon Express Europe a participé pour la première fois à LogiPharma 2023

by

TOKYO, 19 juin 2023 /PRNewswire/ — Nippon Express Europe GmbH, une société du groupe NIPPON EXPRESS HOLDINGS, INC., a participé pour la première fois au salon LogiPharma 2023 qui s’est tenu à Lyon, en France, du mardi 25 avril au jeudi 27 avril. Logo : https://kyodonewsprwire.jp/img/202306136298-O1-VPF88v28 Photo : https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202306136298/_prw_PI2fl_NJKJYRjE.jpg? _ga=2.3372912.1997240702.1686531031-1438572707.1685531252 LogiPharma 2023 est l’un des plus grands salons pharmaceutiques internationaux, axé sur les … Read more